Eleventh Circuit Upholds Florida Fentanyl Conviction in Pain-Medicine Prescription Scheme

The U.S. Court of Appeals for the Eleventh Circuit on Aug. 18 issued its ruling in USA v. Chun, addressing the conviction of a physician specializing in pain medicine and a pharmaceutical sales representative indicted in Florida's Middle District for their roles in a scheme involving a fentanyl-based drug. The ruling is one of a series of decisions the Eleventh Circuit issued this month on cases originating in Florida federal district courts, and it comes as federal authorities across the state continue to press investigations targeting fentanyl-related prescribing and trafficking.

Background of the case

The case originated in the U.S. District Court for the Middle District of Florida, which covers a large swath of the state including Jacksonville, Tampa, Orlando, and Fort Myers. Federal prosecutors charged the physician and the sales representative in connection with prescribing and distribution activities involving a fentanyl-based drug approved for specific medical uses. The federal investigation followed the trail of prescriptions and drug distribution that authorities believed reflected diversion from legitimate medical use.

Fentanyl is a powerful synthetic opioid used in medical settings for severe pain, particularly in cancer patients and in surgical anesthesia. Its potency, roughly 50 to 100 times that of morphine, makes it valuable for legitimate medical uses but also makes it especially dangerous when diverted or misused. Federal law tightly regulates its manufacture, prescription, distribution, and dispensing.

What the appeal argued

Defendants convicted in federal court have the right to appeal to the applicable federal appeals court. The Eleventh Circuit hears appeals from federal district courts in Florida, Georgia, and Alabama, along with certain other federal cases. Appeals typically focus on issues of law such as evidence rulings, jury instructions, sentencing calculations, and the sufficiency of the evidence supporting the verdict.

In the Chun case, arguments focused on whether the district court's rulings on evidence and instructions were correct and whether the sentence imposed reflected proper application of the federal sentencing guidelines. The Eleventh Circuit's panel of judges reviewed the trial record and briefs from both sides before issuing its opinion.

The Eleventh Circuit's ruling

The court's opinion affirms the conviction and addresses the specific issues raised on appeal. Federal appellate opinions typically discuss the applicable legal standards, the facts as developed at trial, and the court's analysis of each issue raised. The written opinion is published on the Eleventh Circuit's website and is available to attorneys, litigants, and the public.

Affirmance of a conviction means the defendant remains subject to the sentence imposed by the district court. In some cases, defendants who lose their direct appeal can pursue further review by filing a petition for rehearing before the same panel or a petition for rehearing en banc, which asks all active judges on the circuit to review the case. In rare cases, the Supreme Court of the United States accepts review through a petition for a writ of certiorari.

Federal enforcement priorities

Federal authorities across Florida have devoted substantial resources to fentanyl-related enforcement. The U.S. Drug Enforcement Administration, the U.S. Department of Justice, and the Health and Human Services Office of Inspector General all have roles in investigating and prosecuting diversion cases involving controlled substances. Local partnerships with the Florida Department of Law Enforcement, state attorneys, and county law enforcement expand the reach of enforcement.

Prescribing patterns, pharmacy dispensing data, and financial records are among the tools investigators use to develop cases. The Prescription Drug Monitoring Program in Florida provides data that helps identify patterns of concern, and state and federal collaboration on the data has been part of the response to the broader opioid crisis.

Fentanyl in Florida

Florida has been affected by the national fentanyl crisis, with overdose deaths involving synthetic opioids a public health concern for years. Naloxone availability, treatment access, and prevention programs have expanded in response, and state and federal agencies coordinate on interdiction efforts targeting illicit fentanyl trafficking.

Illicit fentanyl, often manufactured overseas and smuggled into the country, is distinct from the pharmaceutical fentanyl at issue in the Chun case. Both, however, have contributed to the elevated overdose death toll, and both types of cases work through law enforcement and public health systems.

The Middle District of Florida

The Middle District of Florida is one of three federal judicial districts in the state, alongside the Northern District and the Southern District. The Middle District handles a substantial caseload including significant criminal, civil, and bankruptcy matters. Its courthouses are located in Jacksonville, Tampa, Orlando, Fort Myers, and Ocala.

Federal criminal cases in the Middle District involve prosecutors from the U.S. Attorney's Office for the Middle District of Florida, working with federal law enforcement agencies. Trials are conducted before U.S. District Court judges and juries drawn from the district's population.

Other Eleventh Circuit decisions

The Chun case is one of several the Eleventh Circuit issued on Aug. 18 involving parties or cases with Florida connections. Other decisions the same day included USA v. Andres Alvarado, USA v. Tamara Quicutis et al, USA v. Saleem Hakim, Travelers Property Casualty Insurance Company v. Kamesha Davis, and USA v. Kenneth Mininger. Each of those cases has its own facts and legal issues, and the court's rulings apply the relevant law to the specific circumstances of each case.

On Aug. 20 and Aug. 21, additional rulings were issued in cases including Delta Air Lines, Inc., et al v. U.S. Department of Transportation and various immigration-related petitions. The volume and range of rulings reflects the Eleventh Circuit's substantial docket and its role as the federal appellate court for a large multi-state region.

What comes next

Defendants in cases decided by the Eleventh Circuit typically have limited options after an affirmance. Petitions for rehearing must be filed within specific time windows, and any appeal to the Supreme Court through a writ of certiorari is discretionary and rarely granted. In criminal cases, post-conviction remedies remain available in some circumstances.

Federal investigators and prosecutors will continue to build cases targeting diversion of controlled substances, including fentanyl-based drugs. The Chun ruling adds to a body of appellate precedent that will inform future cases in the district and across the circuit.

Public health context

The medical use of fentanyl serves legitimate patients with severe pain, and the medical community continues to work to balance pain management with the prevention of misuse. Prescriber education, pharmacy monitoring, and patient counseling all play roles in that balance.

Broader public health efforts in Florida address the overdose crisis through prevention, treatment, and recovery services. Statewide and local coalitions bring together health departments, law enforcement, treatment providers, and community organizations to coordinate responses. Federal and state funding supports many of those activities.

The takeaway

The Eleventh Circuit's ruling in USA v. Chun reinforces the seriousness with which federal authorities treat diversion cases involving fentanyl-based drugs. For medical professionals and industry personnel, the case is a reminder of the legal and ethical stakes involved in the prescribing and distribution of controlled substances. For the public, the case reflects the ongoing effort to hold accountable those whose actions contribute to a broader public health crisis.

Federal enforcement, state agency cooperation, and public health initiatives will continue to shape Florida's response to the fentanyl challenge in the months and years ahead.